201. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies.
- Author
-
Takanashi Y, Kahyo T, Sekihara K, Kawase A, Setou M, and Funai K
- Subjects
- Humans, Prognosis, Biomarkers, Tumor metabolism, Mass Spectrometry methods, Female, Lipids blood, Lipids analysis, Male, Breast Neoplasms metabolism, Breast Neoplasms mortality, Breast Neoplasms diagnosis, Prostatic Neoplasms metabolism, Prostatic Neoplasms diagnosis, Lysophospholipids metabolism, Lysophospholipids analysis, Colorectal Neoplasms diagnosis, Colorectal Neoplasms metabolism, Colorectal Neoplasms mortality, Neoplasms metabolism, Neoplasms diagnosis, Neoplasms mortality, Lipidomics methods
- Abstract
Cancer prognosis remains a critical clinical challenge. Lipidomic analysis via mass spectrometry (MS) offers the potential for objective prognostic prediction, leveraging the distinct lipid profiles of cancer patient-derived specimens. This review aims to systematically summarize the application of MS-based lipidomic analysis in prognostic prediction for cancer patients. Our systematic review summarized 38 studies from the past decade that attempted prognostic prediction of cancer patients through lipidomics. Commonly analyzed cancers included colorectal, prostate, and breast cancers. Liquid (serum and urine) and tissue samples were equally used, with liquid chromatography-tandem MS being the most common analytical platform. The most frequently evaluated prognostic outcomes were overall survival, stage, and recurrence. Thirty-eight lipid markers (including phosphatidylcholine, ceramide, triglyceride, lysophosphatidylcholine, sphingomyelin, phosphatidylethanolamine, diacylglycerol, phosphatidic acid, phosphatidylserine, lysophosphatidylethanolamine, lysophosphatidic acid, dihydroceramide, prostaglandin, sphingosine-1-phosphate, phosphatidylinosito, fatty acid, glucosylceramide and lactosylceramide) were identified as prognostic factors, demonstrating potential for clinical application. In conclusion, the potential for developing lipidomics in cancer prognostic prediction was demonstrated. However, the field is still nascent, necessitating future studies for validating and establishing lipid markers as reliable prognostic tools in clinical practice., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF